Trial Profile
Efficacy of DPP-4 inhibitors for oxidative stress and inflammation in type 2 diabetic patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Aug 2017
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Aug 2017 New trial record